Cargando…

Interlaboratory evaluation of plasma N-glycan antennary fucosylation as a clinical biomarker for HNF1A-MODY using liquid chromatography methods

Antennary fucosylation alterations in plasma glycoproteins have been previously proposed and tested as a biomarker for differentiation of maturity onset diabetes of the young (MODY) patients carrying a functional mutation in the HNF1A gene. Here, we developed a novel LC-based workflow to analyze blo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demus, Daniel, Jansen, Bas C., Gardner, Richard A., Urbanowicz, Paulina A., Wu, Haiyang, Štambuk, Tamara, Juszczak, Agata, Medvidović, Edita Pape, Juge, Nathalie, Gornik, Olga, Owen, Katharine R., Spencer, Daniel I. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116301/ https://www.ncbi.nlm.nih.gov/pubmed/33765222 http://dx.doi.org/10.1007/s10719-021-09992-w

Ejemplares similares

Development of an exoglycosidase plate-based assay for detecting α1-3,4 fucosylation biomarker in individuals with HNF1A-MODY
por: Demus, Daniel, et al.
Publicado: (2021)

Impact of sialic acids on the molecular dynamic of bi-antennary and tri-antennary glycans
por: Guillot, Alexandre, et al.
Publicado: (2016)

Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients
por: Hanzawa, Ken, et al.
Publicado: (2022)

A Matrix-Assisted Laser Desorption/Ionization—Mass Spectrometry Assay for the Relative Quantitation of Antennary Fucosylated N-Glycans in Human Plasma
por: Rebello, Osmond D., et al.
Publicado: (2020)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
por: Pavić, Tamara, et al.
Publicado: (2018)

Core-Fucosylated Tetra-Antennary N-Glycan Containing A Single N-Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer
por: Herrera, Harmin, et al.
Publicado: (2019)

Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis
por: Ogawa, Koji, et al.
Publicado: (2020)

Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A case report
por: Forlani, Gabriele, et al.
Publicado: (2010)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
por: Nowak, Natalia, et al.
Publicado: (2012)

Variants influencing age at diagnosis of HNF1A-MODY
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2022)

Metabolic Labeling of Fucosylated Glycans in Developing Zebrafish
por: Dehnert, Karen W., et al.
Publicado: (2011)

Gold Nanoparticles Decorated with Sialic Acid Terminated Bi‐antennary N‐Glycans for the Detection of Influenza Virus at Nanomolar Concentrations
por: Poonthiyil, Vivek, et al.
Publicado: (2015)

Gold Nanoparticles Decorated with Sialic Acid Terminated Bi‐antennary N‐Glycans for the Detection of Influenza Virus at Nanomolar Concentrations
por: Poonthiyil, Vivek, et al.
Publicado: (2015)

Breaking the Limits in Analyzing Carbohydrate Recognition by NMR Spectroscopy: Resolving Branch‐Selective Interaction of a Tetra‐Antennary N‐Glycan with Lectins
por: Canales, Angeles, et al.
Publicado: (2017)

High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes
por: McDonald, Tim J., et al.
Publicado: (2011)

An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY
por: Spiro, Andrew J., et al.
Publicado: (2018)

Circulating CD36 Is Reduced in HNF1A-MODY Carriers
por: Bacon, Siobhan, et al.
Publicado: (2013)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
por: Oosterom, Nicole, et al.
Publicado: (2022)

Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus
por: Nowak, Natalia, et al.
Publicado: (2015)

Asymmetrical Bi-antennary Glycans Prepared by a Stop-and-Go Strategy Reveal Receptor Binding Evolution of Human Influenza A Viruses
por: Ma, Shengzhou, et al.
Publicado: (2023)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
por: Brandes, Gabriela Irene Garcia, et al.
Publicado: (2022)

Genetic and Clinical Characterization of Patients with HNF1B-Related MODY in Croatia
por: Baretić, Maja, et al.
Publicado: (2023)

Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: Is it time to change the diagnostic criteria for MODY?
por: Pruhova, Stepanka, et al.
Publicado: (2013)

Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts
por: Mirshahi, Uyenlinh L, et al.
Publicado: (2022)

Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.
por: Aoyagi, Y., et al.
Publicado: (1993)

Fucosylated N-glycans as early biomarkers of COVID-19 severity
por: Paton, Beatrix, et al.
Publicado: (2023)

Mutations in HNF1A Result in Marked Alterations of Plasma Glycan Profile
por: Thanabalasingham, Gaya, et al.
Publicado: (2013)

FUT8-Directed Core Fucosylation of N-glycans Is Regulated by the Glycan Structure and Protein Environment
por: García-García, Ana, et al.
Publicado: (2021)

Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY
por: Broome, David T., et al.
Publicado: (2020)

Incidence of HNF1A and GCK MODY Variants in a South African Population
por: Matsha, Tandi E, et al.
Publicado: (2020)

YesU from Bacillus subtilis preferentially binds fucosylated glycans
por: Tiralongo, Joe, et al.
Publicado: (2018)

Novel Insights Into N-Glycan Fucosylation and Core Xylosylation in C. reinhardtii
por: Oltmanns, Anne, et al.
Publicado: (2020)

Acceptive Immunity: The Role of Fucosylated Glycans in Human Host–Microbiome Interactions
por: Kononova, Svetlana, et al.
Publicado: (2021)

Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study
por: Locke, Jonathan M., et al.
Publicado: (2021)

MODY probability calculator for GCK and HNF1A screening in a multiethnic background population
por: Tarantino, Roberta Magalhães, et al.
Publicado: (2019)

Insights from basic adjunctive examinations of GCK‐MODY, HNF1A‐MODY, and type 2 diabetes: A systemic review and meta‐analysis
por: Liu, Jing, et al.
Publicado: (2023)

Profiling of core fucosylated N-glycans using a novel bacterial lectin that specifically recognizes α1,6 fucosylated chitobiose
por: Vainauskas, Saulius, et al.
Publicado: (2016)

Increased expression of core-fucosylated glycans in human lung squamous cell carcinoma
por: Ma, Tianran, et al.
Publicado: (2019)

Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
por: Tsai, Kuei-Yen, et al.
Publicado: (2023)

Genomics Meets Glycomics—The First GWAS Study of Human N-Glycome Identifies HNF1α as a Master Regulator of Plasma Protein Fucosylation
por: Lauc, Gordan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_d0herdgeljdkvbihl31er4pc5t